Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention

Table 5 Results of univariate and multivariate analyses at follow-up

	Univariate			Multivariate
	OR	95% CI	P value	OR	95% CI	P value
Age (years)	0.99	0.95–1.02	0.52	0.96	0.92–1.00	0.05
Male—yes	0.88	0.39–2.19	0.77	1.06	0.41–2.95	0.91
BMI (kg/m²)	0.98	0.87–1.09	0.73	0.98	0.86–1.11	0.72
Current smoker—yes	1.42	0.61–3.08	0.40
Family history of premature CAD—yes	0.50	0.18–1.17	0.11	0.37	0.12–0.96	0.04
Systolic blood pressure (mmHg)	1.01	0.99–1.03	0.21
Diastolic blood pressure (mmHg)	1.02	0.99–1.04	0.23
HDL cholesterol (mg/dL)	1.02	0.99–1.04	0.19	1.02	0.99–1.05	0.12
LDL cholesterol (mg/dL)	1.00	0.98–1.02	0.98
Triglyceride (mg/dL)	1.00	0.99–1.01	0.66
Creatinine (mg/dL)	2.08	0.41–9.63	0.36
Hs-CRP (mg/L)	0.79	0.28–1.31	0.46
FBS (mg/dL)	1.01	0.99–1.03	0.33
HbA1c (%)	0.94	0.49–1.70	0.84
1,5-AG (μg/mL)	0.94	0.89–0.99	0.02	0.94	0.89–0.99	0.04
Hypoglycemic therapy—yes	1.47	0.66–3.12	0.34
Anti-hypertensive therapy—yes	0.96	0.39–2.72	0.94
Statin therapy—yes	0.46	0.23–0.92	0.03	0.44	0.21–0.93	0.03
Multiple diseased vessels—yes	2.99	1.41–6.98	0.004	3.41	1.54–8.23	0.002

Age, male gender, BMI, and variables with a P value <0.20 on Univariate analysis were analyzed by multivariate logistic regression
OR odds ratio, CI confidence interval, BMI body-mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, FBS fasting blood glucose, HbA1c hemoglobin A1C, 1,5-AG 1,5-anhydroglucitol

ISSN: 1475-2840